Qualitative dynamics of a vaccination model for HSV-2

被引:20
|
作者
Podder, Chandra N. [1 ]
Gumel, Abba B. [1 ]
机构
[1] Univ Manitoba, Dept Math, Winnipeg, MB R3T 2N2, Canada
关键词
herpes simplex virus type 2; vaccine; equilibria; reproduction number; stability; backward bifurcation; SIMPLEX-VIRUS TYPE-2; BACKWARD BIFURCATIONS; DRUG-RESISTANCE; PUBLIC-HEALTH; HERPES; TRANSMISSION; INFECTION; DISEASE; SEROPREVALENCE; EMERGENCE;
D O I
10.1093/imamat/hxp030
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
A new mathematical model for the transmission dynamics of herpes simplex virus type 2 (HSV-2), which takes into account disease transmission by infected individuals in the quiescent state and an imperfect HSV-2 vaccine, is designed and qualitatively analysed. In the absence of vaccination, it is shown that the model has a globally asymptotically stable (GAS) disease-free equilibrium (DFE) point whenever an epidemiological threshold, known as the 'basic reproduction number', is less than unity. Further, this model has a unique endemic equilibrium whenever the reproduction number exceeds unity. Using a non-linear Lyapunov function, it is shown that the unique endemic equilibrium is GAS (for a special case) when the associated reproduction threshold is greater than unity. On the other hand, the model with vaccination undergoes a vaccine-induced backward bifurcation, where the stable DFE coexists with a stable endemic equilibrium when the reproduction threshold is less than unity. Threshold analysis of the vaccination model reveals that the use of an imperfect HSV-2 vaccine could have positive or negative population-level impact (in reducing disease burden). Simulations of the vaccination model show that an HSV-2 vaccine could lead to effective disease control or elimination if the vaccine efficacy and the fraction of susceptible individuals vaccinated at steady state are high enough (at least 80% each).
引用
收藏
页码:75 / 107
页数:33
相关论文
共 50 条
  • [1] Qualitative dynamics of a vaccination model for HSV-2, (vol 75, pg 75, 2010)
    Podder, Chandra N.
    Gumel, Abba B.
    IMA JOURNAL OF APPLIED MATHEMATICS, 2011, 76 (01) : 217 - 218
  • [2] Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
    Gilbert, Peter B.
    Excler, Jean-Louis
    Tomaras, Georgia D.
    Carpp, Lindsay N.
    Haynes, Barton F.
    Liao, Hua-Xin
    Montefiori, David C.
    Rerks-Ngarm, Supachai
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Kaewkungwal, Jaranit
    Kijak, Gustavo H.
    Tovanabutra, Sodsai
    Francis, Donald P.
    Lee, Carter
    Sinangil, Faruk
    Berman, Phillip W.
    Premsri, Nakorn
    Kunasol, Prayura
    O'Connell, Robert J.
    Michael, Nelson L.
    Robb, Merlin L.
    Morrow, Rhoda
    Corey, Lawrence
    Kim, Jerome H.
    PLOS ONE, 2017, 12 (05):
  • [3] AN AGE-STRUCTURED MODEL FOR THE COUPLED DYNAMICS OF HIV AND HSV-2
    Kapitanov, Georgi
    Alvey, Christina
    Vogt-Geisse, Katia
    Feng, Zhilan
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2015, 12 (04) : 803 - 840
  • [4] Dynamics of HSV-2 infection with a therapeutic vaccine
    Venturino, Ezio
    Shoukat, Affan
    Moghadas, Seyed M.
    HELIYON, 2020, 6 (07)
  • [5] Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection
    Bernstein, DI
    VACCINE, 2000, 18 (14) : 1351 - 1358
  • [6] Vaginal immunity in the HSV-2 mouse model
    Parr, MB
    Parr, EL
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2003, 22 (01) : 43 - 63
  • [7] Review of mathematical models of HSV-2 vaccination: Implications for vaccine development
    Spicknall, Ian H.
    Looker, Katharine J.
    Gottlieb, Sami L.
    Chesson, Harrell W.
    Schiffer, Joshua T.
    Elmes, Jocelyn
    Boily, Marie-Claude
    VACCINE, 2019, 37 (50) : 7396 - 7407
  • [8] A model for the coupled disease dynamics of HIV and HSV-2 with mixing among and between genders
    Alvey, Christina
    Feng, Zhilan
    Glasser, John
    MATHEMATICAL BIOSCIENCES, 2015, 265 : 82 - 100
  • [9] Seminal vesicle fluid increases the efficacy of intravaginal HSV-2 vaccination
    Varese, A.
    Remes Lenicov, F.
    Gonzalez Prinz, M.
    Paletta, A.
    Ernst, G.
    Maeto, C.
    Merlotti, A.
    Sabatte, J.
    Simula, S.
    Holgado, M. P.
    Dantas, E.
    Geffner, J.
    Ceballos, A.
    MUCOSAL IMMUNOLOGY, 2018, 11 (02) : 536 - 548
  • [10] Mucosal vaccination provides protection from HSV-2 infection and disease
    Tucker, Kiersten
    Dave, Veronica
    Lund, Jennifer M.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):